U.S. Industrial REITs Stock News

Alto Ingredients, Inc. previously reported first-quarter 2026 results, with sales of US$224.68 million and net income of US$4.27 million, marking a move from a prior-year loss, and later filed a US$150 million universal shelf registration covering common and preferred stock, debt, warrants, and units. The swing from loss to profit suggests improving earnings quality, while the new shelf registration increases Alto’s flexibility to access capital across multiple security types. Building on...

Wondering if Pinnacle Financial Partners at around US$94.30 is offering value or just noise? This article walks through what the current price might be saying about the stock. The share price is down 5.4% over the past week, roughly flat with a 0.8% decline year to date, yet still up 95.0% over three years and 10.6% over five years. This gives a mixed picture on recent returns. Recent headlines around regional banks have kept investor attention on funding costs, loan growth and credit...

Western Alliance Bancorporation recently declared a quarterly cash dividend on both its common stock and Series A preferred shares, while also disclosing a US$99 million non-performing life-science loan and the immediate resignation of its Chief Banking Officer for National Business Lines. At its 2026 Investor Day, management outlined medium-term profitability targets and plans to exceed US$100 billion in assets, even as it addressed credit issues and leadership turnover that have raised...

MBX Biosciences (NasdaqGS:MBX) reported encouraging preliminary Phase 1 data for its lead obesity candidate, MBX 4291, with early weight loss signals and potential for once-monthly dosing. The company introduced a new preclinical obesity program, MBX 5765, expanding its early stage pipeline. MBX also shared positive proof-of-concept results from its Imapextide Phase 2a trial in post-bariatric hypoglycemia. These updates arrive with MBX Biosciences trading at $37.5, after a very large 1-year...

BridgeBio Pharma (NasdaqGS:BBIO) has submitted a New Drug Application to the FDA for encaleret in autosomal dominant hypocalcemia type 1. The filing follows positive Phase 3 CALIBRATE trial results that met all primary and key secondary endpoints. The company is preparing an EU regulatory submission, signaling plans to pursue approvals beyond the US. The move extends BridgeBio's rare disease pipeline beyond its existing focus on transthyretin amyloid cardiomyopathy. For investors tracking...

Kyivstar Group (NasdaqGS:KYIV) has expanded its collaboration with Starlink, becoming the exclusive provider of fully integrated, multi layer connectivity solutions for Ukrainian businesses and public sector institutions. The arrangement focuses on combining terrestrial and satellite high speed internet to improve coverage, particularly in regions with limited connectivity. The move is positioned as a way to support national infrastructure resilience and broaden Kyivstar Group's role in...

Cboe Global Markets appointed Julie Bauer as Senior Vice President, Head of Government Relations. The new role focuses on global advocacy and regulatory engagement with policymakers and market supervisors. The appointment introduces an experienced policy executive at a time of complex regulatory scrutiny for market infrastructure firms. Cboe Global Markets, ticker BATS:CBOE, is drawing attention after naming Julie Bauer to lead its government relations efforts. The move comes with the stock...

Fortinet and NVIDIA have announced FortiAIGate, a GPU accelerated zero trust security platform focused on protecting AI workloads, data, and autonomous agents. The joint solution is aimed at securing AI deployments across data centers, cloud, and edge environments, with features tailored to AI specific risks such as prompt injection attacks. Fortinet, traded as NasdaqGS:FTNT, is drawing fresh attention with this move into AI focused security infrastructure. The stock recently closed at...

In recent weeks, Ionis Pharmaceuticals announced that the FDA accepted its priority review submissions for olezarsen in severe hypertriglyceridemia and zilganersen in neurology, while the company ramped up launch preparations for both therapies. These regulatory milestones mark an important shift as Ionis moves further into independent commercialization, potentially broadening its treatment footprint beyond rare disease niches. Now, we’ll examine how FDA priority review for olezarsen and...

Fourth quarter earnings put GSI Technology’s recent stock move in context GSI Technology (GSIT) recently reported fourth quarter results, with sales of US$6.32 million and a net loss of US$4.82 million, drawing fresh attention to a stock that has already seen strong recent returns. See our latest analysis for GSI Technology. The earnings release has landed against a backdrop of very strong recent momentum, with a 30 day share price return of 98.30% and a 1 year total shareholder return of...

American Eagle Outfitters (NYSE:AEO) and Bubble Skincare are launching a co-created collection that combines apparel and skincare. The partnership brings a shared focus on community-driven values and Gen Z engagement into a single product line. The collection will be available across American Eagle stores, online, and through TikTok Shop, including a first-time rollout for the company on that platform. For investors watching NYSE:AEO, this collaboration sits at the intersection of fashion,...

Formula One Group recently reported past first-quarter 2026 results, with revenue of US$711 million and net income of US$57 million, both sharply higher than a year earlier. The strong year-on-year jump in profitability suggests the business is converting its growing commercial footprint and content portfolio into meaningfully improved earnings power. Next, we’ll examine how this earnings acceleration, particularly the jump in net income, affects Formula One Group’s broader investment...

Recent attention on Zevra Therapeutics (ZVRA) centers on its first quarter 2026 earnings, where sales and net income figures shifted sharply, and earnings per share turned positive compared with a loss a year earlier. See our latest analysis for Zevra Therapeutics. Those earnings and the recent SDX portfolio sale have come alongside a 30 day share price return of 14.4% and a 90 day share price return of 32.38%, while the 3 year total shareholder return of 127.4% points to momentum that has...

Etsy, NYSE:ETSY, is seeing intensifying competition that is linked to declining buyer activity. The company has reported an annual decline in active buyers and is projecting a sales contraction over the next year. Flat earnings growth alongside higher revenues has raised questions about Etsy's ability to turn demand into stronger profitability. Etsy, NYSE:ETSY, is coming under pressure as buyer activity softens, adding a new layer of risk for a stock that has already been volatile. Shares...

Maravai LifeSciences Holdings (NasdaqGS:MRVI) reported a 41% jump in Q1 2026 revenue. The company sharply narrowed its net loss and posted positive Adjusted EBITDA in the quarter. Results were supported by a large CleanCap vaccine order and meaningful debt reduction. For investors following NasdaqGS:MRVI, this Q1 2026 update marks a clear break from recent coverage that focused on ongoing losses and softer growth. The stock is trading at $4.37, with the share price up 10.9% over the past...

Flutter Entertainment (NYSE:FLUT) is back in focus after trimming its fiscal 2026 outlook and reporting first quarter results that combined strong sales with lower net income, along with leadership changes at core brand FanDuel. See our latest analysis for Flutter Entertainment. Those first quarter results, the trimmed 2026 outlook and leadership changes at FanDuel have come alongside a sharp reset in sentiment, with the share price down 56% year to date and the 1 year total shareholder...

Wondering if Brown-Forman's current share price reflects its true worth, or if the stock might be mispriced based on fundamentals and market expectations. The stock last closed at US$26.16, with returns that were roughly flat year to date at 0.1%, but with declines of 3.0% over the past week, 10.6% over the past month, and 22.4% over the past year, and 55.8% and 62.8% over the past 3 and 5 years respectively. These changes may affect how you think about both risk and potential future...

If you are wondering whether Fluence Energy's current share price still offers value after a strong run, the numbers around recent performance and valuation checks are worth a closer look. The stock trades at US$22.10, with returns of 63.0% over the past week, 61.9% over the past month, a decline of 4.0% year to date, and 305.5% over the last year. This naturally raises questions about how much upside or risk is now priced in. Recent coverage has focused on Fluence Energy's role in energy...

Brunswick (NYSE:BC) is supplying marine platforms, propulsion and electronics for Textron Systems’ TSUNAMI uncrewed surface vessel fleet. The partnership focuses on modular, scalable systems designed for autonomy and defense applications for the U.S. Navy. This agreement extends Brunswick’s marine technology beyond recreational boating into dual use military programs. For investors watching NYSE:BC, this defense collaboration adds a new angle to a company better known for recreational...

LendingClub (NYSE:LC) is rebranding as Happen Bank to reflect its technology focused banking model. The company is shifting its business toward serving institutional loan buyers rather than individual peer to peer investors. Happen Bank is expanding into home improvement lending, with plans to add home equity and mortgage products over time. For you as an investor, the Happen Bank rebrand marks a clear break from LendingClub's peer to peer roots and leans into its role as a digital bank...

Why Black Stone Minerals is on investors' radar Black Stone Minerals (BSM) has drawn fresh attention after recent trading left the stock roughly flat over the year to date, despite a market value of about US$2.87b and reported revenue of US$410.17 million. See our latest analysis for Black Stone Minerals. At a share price of US$13.55, Black Stone Minerals has seen its share price drift lower over the past three months while still producing a positive 1-year total shareholder return of 7.27%...

BorgWarner (BWA) stock has been in focus after the company secured fresh eMotor and turbocharging awards with Asian and European automakers, reported higher year-over-year quarterly earnings, and reaffirmed full-year 2026 guidance. See our latest analysis for BorgWarner. BorgWarner’s recent eMotor and turbocharging wins, along with higher quarterly earnings and reaffirmed 2026 guidance, have coincided with a 24.85% 1 month share price return and a very strong 1 year total shareholder return...

If you are asking whether Dynatrace at US$34.73 is a bargain or a trap, the answer starts with understanding what the current price actually reflects about the business. The stock is down 9.1% over the past week, up 2.9% over the past month, and still down 18.0% year to date and 35.1% over the last year, so investors are clearly reassessing both its potential and its risks. Recent coverage has focused on how software companies are being repriced as investors weigh growth expectations against...

Flex (NasdaqGS:FLEX) has received Board approval to spin off its Power and Cloud business into a separate company called SpinCo. SpinCo is planned as an independent, AI focused power and thermal management company, with current CEO Revathi Advaithi set to lead it. Michael Hartung will become CEO of Flex after the separation, creating two distinct public companies with different business profiles. For investors following NasdaqGS:FLEX, this decision comes with the stock at $143.8 and very...